BVSBioventus Inc.
$12.70+91% 1Y
$12.70
$6.5152 weeks$15.30
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +22% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How BVS is trading
Bioventus Inc. is +91% over the past year while the S&P 500 is +18%: 73 points ahead of the market.
+91%
1-year return · S&P 500 +18%
- vs 200-day average
- +22%
vs 200-day average · a clear uptrend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- 17%
Below its 52-week high
Details›
- Last close2026-10-08
- $12.70
- 1 monthS&P 500 +1.6%
- −6.9%
- 1 yearS&P 500 +18%
- +91%
- 5 yearsS&P 500 +86%
- −10%
- vs 50-day average$13.69
- −7.2%
- 52-week high
- $15.30
- 52-week low
- $6.51
- Annualised volatility
- 55%
| Year | Return |
|---|---|
| 2026 (year to date) | +71% |
| 2025 | −29% |
| 2024 | +99% |
| 2023 | +102% |
| 2022 | −82% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | −8.9% |
| Feb | 5 | 3 of 5 | +4.2% |
| Mar | 6 | 4 of 6 | −1.6% |
| Apr | 6 | 1 of 6 | −10% |
| May | 6 | 3 of 6 | +36% |
| Jun | 6 | 3 of 6 | −4.4% |
| Jul | 6 | 4 of 6 | +16% |
| Aug | 6 | 3 of 6 | +6.5% |
| Sep | 6 | 1 of 6 | −0.98% |
| Oct | 6 | 4 of 6 | +6.8% |
| Nov | 5 | 2 of 5 | −16% |
| Dec | 5 | 3 of 5 | +13% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Devices
Ranks #18 of 51 by RyuScore